Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next
Author: tktrimbath Big red star, 1000 posts Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 2149  
Subject: my mid year review of GERN Date: 6/30/2010 4:30 PM
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Recommendations: 2
INTRO Here's my semi-annual exercise to see if I remember why I own the stocks I own, and so I can check back and see if their stories have changed. I post in case it helps others too.

Geron
GERN (market cap $0.493B)
Geron is a leading edge biotech company focusing (and please excuse the spelling) on stem cells, nuclear cell transfer, telomorase, etc. Basically, they hope to be able to regrow cells to regenerate organs and nerves; and to control cell life and death via telomorase, thereby controlling cancer and possibly prolonging life. They have begun clinical trials and have been delayed by a very cautious FDA.

Geron and GERN continue to be highly speculative in many ways: company, technology, treatment and stock. This will change with progress through the clinical trials, which will take a few more years. That's an improvement because years ago the wait was several years.

I continue to HOLD, and would consider buying more if cash were available and if clinical trials showed dramatic results. Dramatic results are possible considering the impact of accident victims walking again, or cancer patients finding their tumors have shrunk. I don't know if such results are probable, but they do seem possible.

DISCLOSURE LTBH since 1999.
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next

Announcements

Pencils of Promise - Back to School Drive
"Pencils of Promise works with communities across the globe to build schools and create programs that provide education opportunities for children."
Post of the Day:
Apple

Wal-Mart Nixes Apple Pay
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement